---
url: "https://www.lek.com/leadership/peter-rosenorn"
title: "Peter Rosenorn | L.E.K. Consulting"
---

[Skip to main content](https://www.lek.com/leadership/peter-rosenorn#main-content)

[![L.E.K.](https://www.lek.com/themes/lek/images/new-logo.svg)](https://www.lek.com/ "L.E.K.")

Search

- English
- List additional actions
- [Português](https://www.lek.com/pt-br/lek-brazil)
- [简体中文](https://www.lek.com/zh-hant/lek-china)
- [Deutsch](https://www.lek.com/de/lek-germany)
- [日本語](https://www.lek.com/ja/lek-japan)

# Peter Rosenorn

Peter Rosenorn is a Managing Director and Partner in L.E.K. Consulting’s Boston office. He joined L.E.K. in 2010 and specializes in the Life Science & Pharma sector with a focus on growth strategy, organization design and performance improvement. Peter advises clients on a range of critical business issues including organizational scale-up and development, launch planning and commercialization, transaction support, forecasting and valuation, and post-merger integration.

Prior to joining L.E.K., Peter held key global, U.S. and E.U. marketing and sales operations leadership roles at Biogen Idec and Novo Nordisk. He received a Bachelor of Science in Business and a Master of Science in International Marketing and Management from Copenhagen Business School. Additionally, he completed the General Management program at Harvard Business School.

### Education

**Undergraduate:** Bachelor of Science in Business, Copenhagen Business School

**Graduate:** Master of Science in International Marketing and Management, Copenhagen Business School

![Peter Rosenorn, L.E.K. Consulting](https://www.lek.com/sites/default/files/profile-images/peter-rosenorn_web-gmc.jpg)

### Peter's Expertise

#### Industries

[Life Sciences Consulting](https://www.lek.com/industries/life-sciences-pharma)

#### Capabilities

[Strategy](https://www.lek.com/capabilities/strategy)

[Marketing & Sales](https://www.lek.com/capabilities/marketing-and-sales)

[Mergers & Acquisitions](https://www.lek.com/capabilities/mergers-acquisitions)

[Organization Design and Effectiveness](https://www.lek.com/capabilities/organizational-strategy)

[Transformation](https://www.lek.com/capabilities/organizational-strategy/transformation)

[Post-Merger Integration](https://www.lek.com/capabilities/organizational-strategy/post-merger-integration-pmi)

[Organization & Performance](https://www.lek.com/capabilities/organization-performance)

[Performance Improvement](https://www.lek.com/capabilities/performance-improvement)

Read more

### Related Insights

[Executive Insights\\
\\
\\
**Life Sciences & Pharma****When Is It Too Late? Drivers of Commercial Performance for Late Entrants in Biopharma**\\
\\
April 28, 2025](https://www.lek.com/insights/hea/us/ei/when-it-too-late-drivers-commercial-performance-late-entrants-biopharma)

[Executive Insights\\
\\
\\
**Life Sciences & Pharma****Launching Novel CDx for Oncology: 7 Strategies for Biopharma Companies**\\
\\
April 17, 2025](https://www.lek.com/insights/hea/us/ei/launching-novel-cdx-oncology-7-strategies-biopharma-companies)

[Video / Webinar\\
\\
\\
**Life Sciences & Pharma****The Need for Launch Planning**\\
\\
April 25, 2024](https://www.lek.com/insights/hea/global/vd/need-launch-planning)

[Executive Insights\\
\\
\\
**Diagnostics, Tools and Personalized Medicine****Commercial Excellence in Life Sciences Tools and Services Companies**\\
\\
April 8, 2024](https://www.lek.com/insights/hea/us/ei/commercial-excellence-life-sciences-tools-and-services-companies)

[Podcast\\
\\
\\
**Life Sciences & Pharma****Looking Ahead in Biopharma: 2024**\\
\\
January 24, 2024](https://www.lek.com/insights/hea/us/po/looking-ahead-biopharma-2024)

[Executive Insights\\
\\
\\
**Biotech and Pharmaceuticals****Variability in Large Pharma Launch Performance**\\
\\
January 16, 2024](https://www.lek.com/insights/hea/us/ei/variability-large-pharma-launch-performance)

- [Load more](https://www.lek.com/leadership/peter-rosenorn?page=1 "Load more items")

Previous

### Launch Excellence for Biopharma: Planning for Success

![](https://fast.wistia.com/embed/medias/ebtqmq74gy/swatch)

![Video Thumbnail](https://fast.wistia.com/embed/medias/ebtqmq74gy/swatch)

![Video Thumbnail](https://embed-ssl.wistia.com/deliveries/d9de972ed61e70ae74a02042b888c821.webp?image_crop_resized=1920x1080)

Click for sound

4:26

### The Need for Launch Planning

![](https://fast.wistia.com/embed/medias/6hfn5ij0bj/swatch)

![Video Thumbnail](https://fast.wistia.com/embed/medias/6hfn5ij0bj/swatch)

![Video Thumbnail](https://embed-ssl.wistia.com/deliveries/e3a8d5d509acfd32e44583f18b372b40.webp?image_crop_resized=1920x1080)

Click for sound

4:45

Next

![launch excellence ](https://www.lek.com/sites/default/files/teaser-images/launch-excellence-biopharma_teaser.jpg)

##### Biotech and Pharmaceuticals

#### Launch Excellence for Biopharma: Planning for Success

![teaser image](https://www.lek.com/sites/default/files/teaser-images/launch-planning-teaser.jpg)

##### Life Sciences & Pharma

#### The Need for Launch Planning

First name

Last name

Email

Phone number

My locationUnited StatesCanadaAfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia and HerzegovinaBotswanaBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzech RepublicCôte d’IvoireDemocratic Republic of the CongoDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHondurasHong Kong S.A.R., ChinaHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacao S.A.R., ChinaMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth KoreaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestinian TerritoryPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussiaRwandaRéunionSaint BarthélemySaint HelenaSaint Kitts and NevisSaint LuciaSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVaticanVenezuelaViet NamWallis and FutunaWestern SaharaYemenZambiaZimbabwe

Reason for contactingBusiness - I'm exploring hiring L.E.K.Press - I'm a media representative seeking an L.E.K. expert perspectiveCareer - I'm exploring working at L.E.K.Events - I'm looking to invite L.E.K. to participate in an upcoming eventOther

Company

Message

Comments

By clicking “Contact me” I acknowledge and agree to the L.E.K. Consulting [Privacy Notice](https://www.lek.com/lek-consulting-privacy-policy).

×